News
Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and ...
Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...
The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...
The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...
Facility expansions and over 5,800 CGT/ATMP batches manufactured underscore Cellex's strength as a trusted full-service CDMO in Europe.
New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...
RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.
Facility expansions and over 5,800 CGT/ATMP batches manufactured underscore Cellex's strength as a trusted full-service CDMO in Europe. COLOGNE, Germany, June 10, 2025 /PRNewswire/ -- Cellex ...
What began as a leap of faith in 2022 turned into a defining experience of self-discovery, resilience, and career clarity for ...
In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results